Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abaloparatide in Osteoporotic Patients Undergoing Spinal Fusion
NCT07587775Phase 2Enrolling by invitation
- Sponsor
- University at Buffalo
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of abaloparatide in osteoporosis, sponsored by University at Buffalo. Started Jun 2026; status: enrolling by invitation.
02
Drugs
abaloparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07587775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07587775.